Short description
NeuroPace develops and markets implantable devices for the treatment of neurological disorders.
Description
NeuroPace designs develops, manufactures, and markets implantable devices for the treatment of neurological disorders. It offers a responsive Neurostimulator system (RNS) for the treatment of medically refractory partial epilepsy. The company's RNS system consists of implantable components, including RNS neurostimulator that delivers a short train of electrical pulses to the brain, and depth leads and cortical strip leads; and external products, such as the programmer, a laptop computer with proprietary software that has a wand and telemetry interface enabling communication with an implanted RNS neurostimulator.
NeuroPace was incorporated in 1997 and is based in Mountain View, California.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Mountain View, California, United States, North America
Founded on
January 1, 1997
Exited on
April 21, 2021
Went public on
April 21, 2021
Stock symbol
NPCE
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$56378 - 90123
Sign in for full access
Investors
Absolutely Noaccess, Noaccess, Nopepepe, Cannot Access, Nopepepe, Blurry Noaccess, Blurry Noaccess, Blurry Noaccess, Blurry Noaccess, Uh Ohhhh, Noaccess, Absolutely Noaccess, Nopepepe, Noaccess, Uh Ohhhh, Cannot Access, No Way
Sign in for full access
Founders
David Fischell